The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events "are an expected part of any clinical study, especially large studies", but that its physicians and a safety monitoring panel would try to determine what might have caused the illness. However, later the study was resumed in a number of countries, following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. The details of the illness are not revealed due to privacy concerns.
Earlier, pharmaceutical major AstraZeneca had "voluntarily paused" the clinical human trials of its vaccine candidate "Covishield" with the University of Oxford after one of the volunteers developed an unexpected illness.
So far, more than 270,000 people have been recruited to take part in coronavirus vaccine trials around the UK.
While this pause was widely reported as soon as it happened, a first halt in July went under the radar when another United Kingdom patient showed similar symptoms, although they were attributed to the fact that she was already suffering from multiple sclerosis.
Taiwan based TTY Biopharm Company, has announced that it has received authorization for the delivery of coronavirus vaccines developed by Germany's BioNTech SE which is under the phase 3 clinical trials for safety.
The announcement by the British embassy in Bangkok did not specify how many doses of the vaccine candidate, AZD1222, would be distributed in Thailand.
"Supplies such as PPE, needles, syringes and swabs, and freezers to store a vaccine", Hipkins said. That company's testing has restarted elsewhere.
"It is imperative that more people from Black, Asian and different groups sign up to the NHS Registry as soon as possible, so we can ensure Covid-19 vaccines are effective for as many people as possible".
Conducted in line with the highest worldwide standards, volunteers for the UAE trial will be medically supervised for 90 days after taking the vaccine.
Its medical-device unit's sales fell 3.6% to US$6.15 billion, as patients and hospitals continued to delay non-urgent surgeries due to the Covid-19 pandemic.